We are live on ! Find out more
BCI

Brinker Capital Investments Portfolio holdings

AUM $11.7B
1-Year Est. Return 21.33%
This Fund
S&P 500
This Quarter Est. Return
-8.56%
1 Year Est. Return
+21.33%
3 Year Est. Return
+58.92%
5 Year Est. Return
+67.24%
10 Year Est. Return
+168.88%
AUM
$2.86B
AUM Growth
-$358M
Cap. Flow
-$67.2M
Cap. Flow %
-2.35%
Top 10 Hldgs %
23.56%
Holding
692
New
61
Increased
156
Reduced
183
Closed
36

Similar funds

Brinker Capital Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Brinker Capital Investments held 692 positions worth $2.86B, down 11% from $3.22B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Brinker Capital Investments's Q4 2018 filing shows 61 new, 156 increased, 183 reduced and 36 closed positions. Its largest new stake was VanEck Pharmaceutical ETF: 147,000 shares worth $8.05M. The largest sale was iShares MSCI USA Value Factor ETF, an estimated $50.6M.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Brinker Capital Investments's largest Q4 2018 buy was VanEck Pharmaceutical ETF: 147,000 shares worth $8.05M.
  • Brinker Capital Investments added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2018, an estimated $62.5M increase.
  • Brinker Capital Investments's biggest Q4 2018 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $50.6M.
  • Brinker Capital Investments fully exited Vanguard Global ex-US Real Estate ETF in Q4 2018, selling an estimated $27.3M.
  • Brinker Capital Investments's ten largest holdings make up 24% of its $2.86B portfolio in Q4 2018.
  • Brinker Capital Investments opened 61 new positions and closed 36 in Q4 2018.
  • Brinker Capital Investments's portfolio value fell 11% quarter-over-quarter to $2.86B.

Based on Brinker Capital Investments's 13F filing for Q4 2018, filed 13 Feb 2019.